Pricing Log in Create free account

MapLight Therapeutics, Inc. (MPLT) vs Oculis Holding AG (OCS)

MapLight Therapeutics, Inc. and Oculis Holding AG are both Biotechnology companies. MapLight Therapeutics, Inc. and Oculis Holding AG are of similar size ($456.8M and $445.7M). MapLight Therapeutics, Inc. has the higher net margin (0.00% vs −6,870.1%) and the lower return on invested capital (−348.4% vs 0.00%). Across the 13 metrics below, MapLight Therapeutics, Inc. leads on 8 and Oculis Holding AG on 5.

Valuation

Metric MPLT OCS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 303.32 9.71
P/B 1.00 1.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 108.92 9.21
Earnings yield (549.48%) (23.87%) (33.15%)
Free cash flow yield (50.06%) (18.51%) (25.50%)

Profitability

Metric MPLT OCS Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (7,383.66%) 0.00%
Net margin 0.00% (6,870.05%) 0.00%
Free cash flow margin 0.00% (5,525.64%) 0.00%
Return on equity (297.18%) (44.87%) (56.36%)
Return on assets (124.79%) (37.69%) (48.04%)
Return on invested capital (348.44%) 0.00% 0.00%

Growth

Metric MPLT OCS Biotechnology median
Revenue growth (TTM) — 65.83% 6.02%
EPS growth (last fiscal year) 82.39% 5.39% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric MPLT OCS Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 16.52 8.35 4.72
Net debt to EBITDA 1.79 2.60 0.96

Dividend

Metric MPLT OCS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MPLT OCS Biotechnology median
Market cap 445.72m 456.82m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack